Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/5/14 → 5/5/17 |
Funding
- Parexel (Prot #R1033-SRC-1239 // Prot #R1033-SRC-1239)
- Regeneron Pharmaceuticals, Inc. (Prot #R1033-SRC-1239 // Prot #R1033-SRC-1239)
Prot #R1033-SRC-1239: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of 3-Month Subcutaneous REGN 1033 Treatment in Patients with Sarcopenia
- McDermott, Mary M (PD/PI)
Project: Research project